LSBRX
Price
$11.74
Change
-$0.03 (-0.25%)
Updated
May 2 closing price
Net Assets
4.35B
PONRX
Price
$10.59
Change
-$0.04 (-0.38%)
Updated
May 2 closing price
Net Assets
182.45B
Ad is loading...

LSBRX vs PONRX

Header iconLSBRX vs PONRX Comparison
Open Charts LSBRX vs PONRXBanner chart's image
Loomis Sayles Bond Retail
Price$11.74
Change-$0.03 (-0.25%)
VolumeN/A
Net Assets4.35B
PIMCO Income R
Price$10.59
Change-$0.04 (-0.38%)
VolumeN/A
Net Assets182.45B
LSBRX vs PONRX Comparison Chart
Loading...
View a ticker or compare two or three
VS
LSBRX vs. PONRX commentary
May 05, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is LSBRX is a Buy and PONRX is a Hold.

Ad is loading...
FUNDAMENTALS
Fundamentals
PONRX has more cash in the bank: 182B vs. LSBRX (4.35B). PONRX pays higher dividends than LSBRX: PONRX (5.54) vs LSBRX (5.20). LSBRX was incepted earlier than PONRX: LSBRX (28 years) vs PONRX (18 years). PONRX (1.48) is less costly to investors than LSBRX (0.95). PONRX is a more actively managed with annual turnover of: 588.00 vs. LSBRX (62.00). LSBRX (0) and PONRX (0) have matching initial minimum investment requirements. LSBRX annual gain was more profitable for investors over the last year : 9.96 vs. PONRX (7.05). PONRX return over 5 years is better than : 21.97 vs. LSBRX (18.59).
LSBRXPONRXLSBRX / PONRX
Total Expense Ratio0.901.4861%
Annual Report Gross Expense Ratio0.951.4864%
Fund Existence28 years18 years-
Gain YTD2.2012.54686%
Front LoadN/AN/A-
Min. Initial Investment00-
Min. Initial Investment IRAN/AN/A-
Net Assets4.35B182B2%
Annual Yield % from dividends5.205.5494%
Returns for 1 year9.967.05141%
Returns for 3 years11.9215.0079%
Returns for 5 years18.5921.9785%
Returns for 10 years13.3842.5431%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ALT5.770.60
+11.61%
Altimmune
ADAP0.290.01
+3.93%
Adaptimmune Therapeutics plc
CVX138.502.24
+1.64%
Chevron Corp
NXT42.200.33
+0.79%
Nextracker
TLRY0.46-0.03
-6.26%
Tilray Brands